Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity
Jing Lin, Shihui Sun, Kui Zhao, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy
Liang Zhang, An Song, Qi‐Chao Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 94
Bioorthogonal Disruption of Pyroptosis Checkpoint for High-Efficiency Pyroptosis Cancer Therapy
Bin Zhang, Zhengwei Liu, Jiawei Zhu, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 30, pp. 16658-16668
Closed Access | Times Cited: 57
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective
Yifan Liu, Renjie Pan, Yuzhen Ouyang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
The gasdermin family: emerging therapeutic targets in diseases
Cheng‐long Zhu, Sheng Xu, Ruoyu Jiang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity
Shuo Wang, An Song, Jun Xie, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Recent strategies for evoking immunogenic Pyroptosis in antitumor immunotherapy
Zhangxin He, Dexiang Feng, Chaoji Zhang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 375-394
Open Access | Times Cited: 16
Gasdermin E dictates inflammatory responses by controlling the mode of neutrophil death
Fengxia Ma, Laxman Ghimire, Qian Ren, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Tumor Vaccines: Unleashing the Power of the Immune System to Fight Cancer
Dequan Liu, Xiangyu Che, Xiaoxi Wang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1384-1384
Open Access | Times Cited: 32
Biomaterials Elicit Pyroptosis Enhancing Cancer Immunotherapy
Meng‐Jie Zhang, Yuanyuan Wang, Lin‐Lin Han, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 7
Closed Access | Times Cited: 24
The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles
Yixiang Hu, Ya Liu, Lijuan Zong, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 22
Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppression
Yunna Chen, Qianqian Zhou, Zongfang Jia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 3834-3854
Open Access | Times Cited: 13
Programmed cell death in tumor immunity: mechanistic insights and clinical implications
Man Wang, Fei Yu, Yuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 9
Dual-Responsive Epigenetic Inhibitor Nanoprodrug Combined with Oncolytic Virus Synergistically Boost Cancer Immunotherapy by Igniting Gasdermin E-Mediated Pyroptosis
Yuanyuan Wang, Jingting Wang, Shuo Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 31, pp. 20167-20180
Closed Access | Times Cited: 9
Harnessing Pyroptosis for Cancer Immunotherapy
Christopher M. Bourne, Cornelius Y. Taabazuing
Cells (2024) Vol. 13, Iss. 4, pp. 346-346
Open Access | Times Cited: 7
Apoptosis‐Sensitizing Tumor Nanomedicine by Regulating Pyroptosis‐Associated Inflammatory Cell Death
Fangxue Du, Hongxin Zhao, Yangmeihui Song, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 44
Closed Access | Times Cited: 7
Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation
Si-Jia Sun, Xiao‐Dong Jiao, Zhigang Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells
Jordon M. Inkol, Michael J. Westerveld, Shayla Grace Verburg, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e006781-e006781
Open Access | Times Cited: 6
PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF–caspase 8–GSDMD/E axis in ovarian cancer
Yu Xia, Pu Huang, Yiyu Qian, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009032-e009032
Open Access | Times Cited: 6
Recent advances in oncolytic virus therapy for hepatocellular carcinoma
Licheng Zhu, Yu Lei, Jia Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Nanotechnology Applications in Breast Cancer Immunotherapy
Ruijie Wang, Pramod Kumar, Moataz Reda, et al.
Small (2023)
Closed Access | Times Cited: 13
Role of tumor cell pyroptosis in anti-tumor immunotherapy
Lincheng Zhang, Haotian Bai, Jing Zhou, et al.
Cell Insight (2024) Vol. 3, Iss. 3, pp. 100153-100153
Open Access | Times Cited: 5
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Engineering materials for pyroptosis induction in cancer treatment
Jiayi Liu, Taili Chen, XianLing Liu, et al.
Bioactive Materials (2023) Vol. 33, pp. 30-45
Open Access | Times Cited: 12
Antibody-dependent enhancement of ORFV uptake into host cells
Xidian Tang, Can Zhang, Qingru Geng, et al.
Virulence (2025) Vol. 16, Iss. 1
Open Access
Development of attenuated Orf virus as a safe oncolytic viral vector for nasopharyngeal carcinoma treatment
Yumiko Yamada, Yu‐Chih Wang, Hao‐Ping Liu, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top